Search

everythinglearnresearchcommunity

for

Search:↓

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Baricitinib may effectively treat nail changes in alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Injectable Platelet Rich Fibrin effectively improves hair growth in males with hair loss.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Pulsed electric field treatment may help shrink untreated liver tumors.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.